Brief: Epirus Biopharmaceuticals reports Q2 loss of $0.65 per share

Epirus Biopharmaceuticals

07/08/2015 12:00

Aug 7 (Reuters) - EPIRUS Biopharmaceuticals Inc  EPRS.O : 
 * Reports second quarter 2015 financial results 
 * Q2 loss per share $0.65 
 * Q2 earnings per share view $-0.38 -- Thomson Reuters I/B/E/S 
 * Research and development expenses were $8.3 million for Q2 2015 versus $2.6 
   million for Q2 2014 
 
 * Source text for Eikon  ID:nGNXLTIEKa  
 
 * Further company coverage  EPRS.O  
 
 ((Bengaluru Newsroom; +1 646 223 8780))